Encinitas, CA, United States of America

Deborah Helen Slee

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovations of Deborah Helen Slee

Introduction

Deborah Helen Slee is a prominent inventor based in Encinitas, California, recognized for her significant contributions to the field of pharmaceuticals. With a total of 12 patents to her name, Slee has made groundbreaking advancements in the treatment of various medical conditions, including cancer and pain management.

Latest Patents

Among her latest innovations are two notable patents. The first patent pertains to EGFR inhibitor compounds, which disclose nitrogen-containing bicyclic compounds that include pharmaceutically acceptable salts. These compounds are designed for use in pharmaceutical compositions and offer novel methods for ameliorating and/or treating cancers. The second patent focuses on analgesic compounds, detailing various formulae along with methods for synthesizing and utilizing these compounds as pain relievers. This work showcases her commitment to developing effective therapeutic solutions.

Career Highlights

Throughout her career, Deborah Slee has been associated with reputable companies such as Recurium IP Holdings, LLC and Zeno Royalties & Milestones, LLC. Her work in these organizations has enabled her to explore and innovate within the pharmaceutical landscape, leading to her impressive portfolio of patents.

Collaborations

Deborah has collaborated with notable individuals in her field, including her coworkers Kevin Duane Bunker and Chad Daniel Hopkins. These collaborations highlight her ability to work effectively within multidisciplinary teams, contributing to the advancement of medical therapies.

Conclusion

Deborah Helen Slee’s contributions to the field of pharmaceuticals demonstrate her ingenuity and dedication as an inventor. With her ongoing commitment to research and innovation, she continues to pave the way for new treatments that may significantly impact healthcare outcomes. Her impressive array of patents and collaborations reflects her status as a leading figure in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…